ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,080.95
-1.00%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Verve Therapeutics Inc (VERV) Quote

Verve Therapeutics Inc

Verve Therapeutics Inc (VERV)

Verbund Ag
Verbund Ag
Verbund Ag
Verbund Ag
6.16
-0.16
(-2.53%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
6.0018
-0.1582
(-2.57%)
After Hours: 7:52PM
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.0018
Bid
5.76
Ask
6.16
Volume
1,711,600
5.88 Day's Range 6.2553
2.8647 52 Week Range 9.305
Market Cap
535.02M
Previous Close
6.32
Open
5.99
Last Trade
30
@
6.1
Last Trade Time
Financial Volume
$ 10,453,685
VWAP
6.1076
Average Volume (3m)
3,671,240
Shares Outstanding
89,143,237
Dividend Yield
-
PE Ratio
-2.76
Earnings Per Share (EPS)
-2.23
Revenue
32.33M
Net Profit
-198.71M

About Verve Therapeutics Inc

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.vervetx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Verve Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VERV. The last closing price for Verve Therapeutics was $6.32. Over the last year, Verve Therapeutics shares have traded in a share price range of $ 2.8647 to $ 9.305.

Verve Therapeutics currently has 89,143,237 shares outstanding. The market capitalization of Verve Therapeutics is $563.39 million. Verve Therapeutics has a price to earnings ratio (PE ratio) of -2.76.

Ask ADVFN Intelligence (AI)

VERV Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 10 2025
VERV (-2.53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
VERV (-2.53%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 14 2025
VERV (-2.53%)

Form 8-K - Current report
Edgar (US Regulatory)
May 14 2025
VERV (-2.53%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 25 2025
VERV (-2.53%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.15182.594871794875.856.66755.77228366536.24488004CS
41.631837.34096109844.376.66753.8930398015.12254074CS
120.651812.18317757015.356.66752.864736712404.69343582CS
26-0.0382-0.6324503311266.049.3052.864725024355.28319996CS
520.41187.366726296965.599.3052.864719487935.43105136CS
156-6.0082-50.026644462912.01432.8647134789311.63239302CS
260-23.9982-79.99430782.8647114978014.35046848CS

VERV - Frequently Asked Questions (FAQ)

What is the current Verve Therapeutics share price?
The current share price of Verve Therapeutics is $ 6.0018
How many Verve Therapeutics shares are in issue?
Verve Therapeutics has 89,143,237 shares in issue
What is the market cap of Verve Therapeutics?
The market capitalisation of Verve Therapeutics is USD 563.39M
What is the 1 year trading range for Verve Therapeutics share price?
Verve Therapeutics has traded in the range of $ 2.8647 to $ 9.305 during the past year
What is the PE ratio of Verve Therapeutics?
The price to earnings ratio of Verve Therapeutics is -2.76
What is the cash to sales ratio of Verve Therapeutics?
The cash to sales ratio of Verve Therapeutics is 16.98
What is the reporting currency for Verve Therapeutics?
Verve Therapeutics reports financial results in USD
What is the latest annual turnover for Verve Therapeutics?
The latest annual turnover of Verve Therapeutics is USD 32.33M
What is the latest annual profit for Verve Therapeutics?
The latest annual profit of Verve Therapeutics is USD -198.71M
What is the registered address of Verve Therapeutics?
The registered address for Verve Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Verve Therapeutics website address?
The website address for Verve Therapeutics is www.vervetx.com
Which industry sector does Verve Therapeutics operate in?
Verve Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

VERV Discussion

View Posts
BottomBounce BottomBounce 1 month ago
$VERV Cholesterol is NOT the enemy! pic.twitter.com/gbeQGfoft9— Died Suddenly (@DiedSuddenly_) May 9, 2025
👍️0
Monksdream Monksdream 1 month ago
VERV 10Q due Monday 5/5
👍️0
Monksdream Monksdream 2 months ago
VERV up off a recent 52/week low
👍️0
glenn1919 glenn1919 2 months ago
VERV.................................................................................p/m
👍️0
glenn1919 glenn1919 2 months ago
VERV................................https://stockcharts.com/h-sc/ui?s=VERV&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 months ago
VERV 10Q due Monday 2/24
👍️0
Monksdream Monksdream 10 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 10 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 10 months ago
VERV 10Q due AUGUST5
👍️0
Monksdream Monksdream 12 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 12 months ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV more new lows up ahead
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VERV new 52 lo
👍️0
Firestorm22 Firestorm22 1 year ago
uh oh
👍️0
Monksdream Monksdream 1 year ago
VERV over $10
👍️0
fink fink 1 year ago
Looking for an entry now
👍️0
Terpi Terpi 2 years ago
Could see another nice move here is the 50 day holds into close.
👍️0
Monksdream Monksdream 2 years ago
VERV morning rally
👍️0
TheFinalCD TheFinalCD 2 years ago
https://cathiesark.com/
👍️0
crudeoil24 crudeoil24 3 years ago
VERV IS A GREAT $$$$$ OPPORTUNITY.
👍️0
crudeoil24 crudeoil24 3 years ago
Verve Therapeutics started at outperform with $48 stock price target at BMO Capital
👍️0
crudeoil24 crudeoil24 3 years ago
Verve Therapeutics, Inc. is a genetic medicines company, developing an approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The Company’s initial two programs target PCSK9 and ANGPTL3, respectively, genes that regulate levels of blood lipids. Its lead product candidate, VERVE-101, is designed to permanently turn off the PCSK9 gene in the liver. Reduction of PCSK9 protein in the blood improves the ability of the liver to clear LDL-C from the blood. VERVE-101 utilizes LNP-mediated delivery to target the liver and base editing technology to make a single base change at a specific site in the PCSK9 gene in order to disrupt PCSK9 protein production. It is advancing VERVE-101 initially for the treatment of heterozygous familial hypercholesterolemia. Its second program is designed to permanently turn off the ANGPTL3 gene in the liver. ANGPTL3 is a key regulator of cholesterol and triglyceride metabolism.
👍️0

Your Recent History

NASDAQ
VERV
Verve Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads